{"title":"制药公司向国民保健服务托管机构付款","authors":"BMJ Publishing Group Ltd","doi":"10.1136/dtb.2024.000031","DOIUrl":null,"url":null,"abstract":"### Key points Analysis of data from the Disclosure UK database shows that more than 90% of NHS trusts in England received non-research-related payments from pharmaceutical companies between 2015 and 2018.1 The authors of the study used data from the Disclosure UK database (https://search.disclosureuk.org.uk/) which contains details of payments and benefits in kind made by the pharmaceutical industry to organisations and health professionals in the UK.1 Information relating to payments made during 4 years …","PeriodicalId":11277,"journal":{"name":"Drug and Therapeutics Bulletin","volume":"2 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pharmaceutical company payments to NHS trusts\",\"authors\":\"BMJ Publishing Group Ltd\",\"doi\":\"10.1136/dtb.2024.000031\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"### Key points Analysis of data from the Disclosure UK database shows that more than 90% of NHS trusts in England received non-research-related payments from pharmaceutical companies between 2015 and 2018.1 The authors of the study used data from the Disclosure UK database (https://search.disclosureuk.org.uk/) which contains details of payments and benefits in kind made by the pharmaceutical industry to organisations and health professionals in the UK.1 Information relating to payments made during 4 years …\",\"PeriodicalId\":11277,\"journal\":{\"name\":\"Drug and Therapeutics Bulletin\",\"volume\":\"2 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug and Therapeutics Bulletin\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/dtb.2024.000031\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug and Therapeutics Bulletin","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/dtb.2024.000031","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
### Key points Analysis of data from the Disclosure UK database shows that more than 90% of NHS trusts in England received non-research-related payments from pharmaceutical companies between 2015 and 2018.1 The authors of the study used data from the Disclosure UK database (https://search.disclosureuk.org.uk/) which contains details of payments and benefits in kind made by the pharmaceutical industry to organisations and health professionals in the UK.1 Information relating to payments made during 4 years …
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
